- Poster presentation
- Open Access
Effect of enteral and/or parenteral glutamine supplementation on mortality and morbidity in the critically ill
Critical Care volume 18, Article number: P424 (2014)
In this study we aimed to compare the effectiveness of enteral, parenteral and combined enteral-parenteral glutamine supplementations in the nutrition of critical care patients.
This is a single-center, randomized controlled clinical trial. During the 5-day study period, all patients received standard enteral nutrition product and were divided into three groups, including parenteral glutamine (Group I), enteral glutamine (Group II) and enteral + parenteral glutamine (Group III) supplementations. Blood biochemistry, rates of infections, length of stay in the ICU and duration of mechanical ventilation were evaluated.
Sixty patients were included in this study. There was no statistically significant difference for biochemical values between the different feeding groups. Frequency of infections ranged as Group II >Group III >Group I and mortality as Group II = Group III >Group I. Length of stay in the ICU and duration of mechanical ventilation were significantly longer in Group II than the others.
Although mortality was not significantly different between groups, parenteral glutamine administration causes less stay of ICU and mechanical ventilation. This needs a more powerful randomized controlled study .
Estívariz CF, et al.: J Parenter Enteral Nutr. 2008, 32: 389-402. 10.1177/0148607108317880
About this article
Cite this article
Sungurtekin, H., Ozturk, I., Beder, B. et al. Effect of enteral and/or parenteral glutamine supplementation on mortality and morbidity in the critically ill. Crit Care 18 (Suppl 1), P424 (2014). https://doi.org/10.1186/cc13614
- Mechanical Ventilation
- Critical Care
- Control Clinical Trial
- Enteral Nutrition